Characterisation of the BRCT Domains of the Breast Cancer Susceptibility Gene Product BRCA1
Authors:
- H.R WilkinsonHWH.R Wilkinson
- J.W.H SchymkowitzJSJ.W.H Schymkowitz
- F RousseauFRF Rousseau
- S.M.V FreundSFS.M.V Freund
- L.S ItzhakiL.S Itzhaki
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 320 (3) , 431-442
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structureGenes & Development, 2002
- Prediction of deleterious human allelesHuman Molecular Genetics, 2001
- BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10alpha in activated transcriptionProceedings of the National Academy of Sciences, 2000
- Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapyOncogene, 2000
- Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage ResponseScience, 1999
- BRCA1 physically associates with p53 and stimulates its transcriptional activityOncogene, 1998
- Common BRCA1 Variants and Transcriptional ActivationThe American Journal of Human Genetics, 1997
- Growth retardation and tumour inhibition by BRCA1Nature Genetics, 1996
- Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosomeNature Genetics, 1992
- Probing the stability of a partly folded apomyoglobin intermediate by site-directed mutagenesisBiochemistry, 1991